Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 8

The association between COPD and heart failure risk: a review

Authors de Miguel Díez J, Chancafe Morgan J, Jiménez García R

Published Date June 2013 Volume 2013:8 Pages 305—312

DOI http://dx.doi.org/10.2147/COPD.S31236

Received 28 February 2013, Accepted 12 April 2013, Published 28 June 2013

Javier de Miguel Díez,1 Jorge Chancafe Morgan,1 Rodrigo Jiménez García2

1Pulmonology Department, Gregorio Maranon University Hospital, Complutense University of Madrid, Madrid, Spain; 2Preventive Medicine and Public Health Teaching and Research Unit, Department of Health Sciences, Rey Juan Carlos University, Madrid, Spain

Abstract: Chronic obstructive pulmonary disease (COPD) is commonly associated with heart failure (HF) in clinical practice since they share the same pathogenic mechanism. Both conditions incur significant morbidity and mortality. Therefore, the prognosis of COPD and HF combined is poorer than for either disease alone. Nevertheless, usually only one of them is diagnosed. An active search for each condition using clinical examination and additional tests including plasma natriuretic peptides, lung function testing, and echocardiography should be obtained. The combination of COPD and HF presents many therapeutic challenges. The beneficial effects of selective ß1-blockers should not be denied in stable patients who have HF and coexisting COPD. Additionally, statins, angiotensin-converting enzyme inhibitors, and angiotensin-receptor blockers may reduce the morbidity and mortality of COPD patients. Moreover, caution is advised with use of inhaled ß2-agonists for the treatment of COPD in patients with HF. Finally, noninvasive ventilation, added to conventional therapy, improves the outcome of patients with acute respiratory failure due to hypercapnic exacerbation of COPD or HF in situations of acute pulmonary edema. The establishment of a combined and integrated approach to managing these comorbidities would seem an appropriate strategy. Additional studies providing new data on the pathogenesis and management of patients with COPD and HF are needed, with the purpose of trying to improve quality of life as well as survival of these patients.

Keywords: chronic obstructive pulmonary disease, heart failure

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Determinants and predictors of the cost of COPD in primary care: A Spanish perspective

Javier de Miguel Diez, Pilar Carrasco Garrido, Marta García Carballo, Angel Gil de Miguel, Javier Rejas Gutierrez, et al

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:701-712

Published Date: 2 September 2008

Readers of this article also read:

Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease

Kubota Y, Asai K, Furuse E, Nakamura S, Murai K, Tsukada YT, Shimizu W

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:515-523

Published Date: 5 March 2015

Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?

Echave-Sustaeta JM, Comeche Casanova L, Cosio BG, Soler-Cataluña JJ, Garcia-Luján R, Ribera X

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:1307-1314

Published Date: 19 November 2014

Inhaled anticholinergic use and all-cause mortality among elderly Medicare beneficiaries with chronic obstructive pulmonary disease

Ajmera M, Shen C, Pan X, Findley PA, Rust G, Sambamoorthi U

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:287-294

Published Date: 10 June 2013

Day-to-day measurement of patient-reported outcomes in exacerbations of chronic obstructive pulmonary disease

Kocks JWH, van den Berg JWK, Kerstjens HAM, Uil SM, Vonk JM, de Jong YP, Tsiligianni IG, van der Molen T

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:273-286

Published Date: 6 June 2013

Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case–control study (CONSISTE study)

de Lucas-Ramos P, Izquierdo-Alonso JL, Rodriguez Gonzalez-Moro JM, Fernandez Frances J, Vaquero Lozano P, Bellón-Cano JM

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:679-686

Published Date: 1 October 2012

Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease

Ito K, Colley T, Mercado N

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:641-652

Published Date: 21 September 2012